Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for November 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Sanofi-Aventis to collaborate with French biotech company on Alzheimer's disease
Hopes that research could lead to immunisation breakthrough..(more)

 Merck looks to traditional medicine in cancer research
Collaboration with Chi-Med builds pharma's R&D presence in China..(more)

 NICE to face judicial review over Alzheimer's drug decision
Eisai/Pfizer reequest withdrawal of the Final Appraisal Determination..(more)

 Sanofi-Aventis to expand diabetes and thrombosis work with Euro RSCG
Euro RSCG secures promotion of current and future products..(more)

 NICE to say no to Tarceva
Institute's preliminary appraisal says drug is too expensive..(more)

 Future global R&D for Bayer Schering defined
Massive cost savings expected but merger will lead to loss of 800 US jobs..(more)

 Surprise delay for Novartis' Galvus
FDA to scrutinise new safety data relating to skin toxicity..(more)

 US Democrats to target pharmaceutical prices
Pharma hopes Medicare expansion could offset price cuts..(more)

 Roche sponsor early breast cancer leaflet
Ask About Medicines campaign encourages patients to quiz doctors..(more)

 iPod-ready patient information leaflets coming soon
New service will help visually-impaired patients learn about their medicines..(more)

 Genentech to buy biotech Tanox for $900 million
Acquisition will boost company's monoclonal antibody pipeline..(more)

 Abbott buys cholesterol drug specialists Kos
Acquisition will expand Abbott's presence in lipid management, diabetes and asthma markets..(more)

 'Pulsed' vitamin D drug could transform advanced prostate cancer treatment
Novacea's Asentar shows impressive results in phase II trials ..(more)

 Sepsis drug put back at least two years
AstraZeneca must carry out second phase II trial on CytoFab..(more)

 Once-a-day colitis drug could take on the leaders
Trials suggest Shire's drug more likely to achieve patient compliance..(more)

 Novartis to be first pharma to conduct R&D in China
$100 milion investment signifies company's long-term commitment to Asian market..(more)

 Teva and Schering-Plough UK to collaborate on bowel drug
Companies will work together to launch attack on current market leader..(more)

 New clinical trials agreement to improve UK research
Updated contract should give patients earlier access to new drugs..(more)

 New drive to cut millions from branded sales on NHS
DH actively looking at introducing targets for generic precribing..(more)

 UK industry launches 'manifesto' to speed uptake of new medicines
ABPI says UK patients are being 'short-changed'..(more)

 Bristol-Myers Squibb suffers at hands of generic Plavix
Third quarter sales down by $600 million..(more)

 Protest against NHS cuts gathers momentum
Thousands turn out in rallies across the country..(more)

 Most PCTs not funding Pfizer's Macugen
Campaigners' survey reveals widespread lack of access..(more)

 Modified mice could speed safe drug discoveries
'Humanised' mice may be first in a series of commercial biotech milestones..(more)

 GSK suffers pipeline setbacks
Key products dropped or delayed lower quarterly figures..(more)

 NHS staff unite in protest against government policies
Healthcare leaders call for halt to reforms at Westminster rally..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.